Spineart reçoit l'autorisation 510(k) pour la cage cervicale antérieure SCARLET® AC-Ti

GENÈVE, 28 mai 2024 /PRNewswire/ -- Spineart, une entreprise à croissance rapide spécialisée dans la chirurgie de la colonne vertébrale, est fière d'annoncer l'autorisation 510(k) de la Food and Drug Administration (FDA) des États-Unis pour sa cage cervicale antérieure sécurisée SCARLET®...

Back to Health Page

Spineart reçoit l'autorisation 510(k) pour la cage cervicale antérieure SCARLET® AC-Ti

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Mu

Health Catalyst Announces New Credit Facility for up to $225,000,000

Leukemia Survivor Named National 'Visionary of the Year' Redefining What's Possible After Diagnosis

Original programming means a lot less to Netflix these days, says Tom Rogers

By 2034, Recombinant Proteins Market Size Projected to Grow USD 4.68 Billion, at 7.9% CAGR: Prophecy

New infection found in China 'never seen before in humans' and 'bodes badly for future'

COMPASS SURGICAL PARTNERS APPOINTS DARCY SMITH CHIEF PEOPLE OFFICER

Do You Want To Tone Down Your Waist? Malaika Arora Suggests You Do These Exercises

Certify Releases Blueprint Report for Provider Credentialing Automation

Saluda Medical Announces Presentation of Two Chronic Pain Biomarker-Based Analyses at ASPN 2024 Annual Conference

Urgency called on disposable glove contamination, say experts

MedGenome boosts omic insights capabilities as the first commercial provider in the San Francisco Bay Area of California to bring PacBio Revio in-house with full service capability

Sidecar Health and ProMedica forge innovative agreement to improve health care access in Ohio

National Multiple Sclerosis Society Names Dr. Tim Coetzee as New President and CEO

Spineart reçoit l'autorisation 510(k) pour la cage cervicale antérieure SCARLET® AC-Ti

Newsletter Subscription